Genetic Detection of Candida albicans and Measurement of IL-17 Levels in Rheumatoid Arthritis Patients: A Study Using Conventional PCR and ELISA Techniques

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation and progressive joint destruction. Increasing evidence suggests that fungal dysbiosis may influence immune responses through the interleukin-17A (IL-17A) pathway. This study aimed to determine the prevalence of peripheral blood Candida albicans DNA in patients with RA, quantify serum IL-17A concentrations, and evaluate the association between fungal DNA positivity and IL-17A levels. A total of 100 participants, including 50 patients with RA and 50 healthy controls, were enrolled. Candida albicans DNA was detected by conventional polymerase chain reaction (PCR) targeting the INT1 gene, while serum IL-17A concentrations were measured using enzyme-linked immunosorbent assay (ELISA). The association between fungal DNA positivity and serum IL-17A concentrations was assessed using point-biserial correlation analysis. Candida albicans DNA was detected significantly more frequently in RA patients than in healthy controls (38% vs. 10%; p < 0.001). Serum IL-17A concentrations were significantly higher in RA patients, with the highest levels observed in C. albicans-positive patients (46.2 ± 8.7 pg/mL), followed by C. albicans-negative RA patients (32.5 ± 6.4 pg/mL) and healthy controls (15.1 ± 5.2 pg/mL) (p < 0.001). Point-biserial correlation analysis demonstrated a significant positive association between C. albicans DNA positivity and serum IL-17A concentrations (rpb = 0.672, p < 0.001). Peripheral blood Candida albicans DNA positivity was associated with elevated serum IL-17A concentrations in patients with RA. These findings support an association between fungal DNA detection and enhanced IL-17A-mediated immune responses; however, the cross-sectional design precludes any inference of causality. Further longitudinal studies incorporating quantitative fungal detection are warranted.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-07-30
DOI
https://doi.org/10.3390/ijms27156831
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genetic Detection of Candida albicans and Measurement of IL-17 Levels in Rheumatoid Arthritis Patients: A Study Using Conventional PCR and ELISA Techniques

Mehmet Gökhan Halıcı, Farah Thamer Samawi, Abdullah AbdulKareem Ahmed Al-Obaidi
International Journal of Molecular Sciences
Psoriasis: Treatment and Pathogenesis
article

Genetic Detection of Candida albicans and Measurement of IL-17 Levels in Rheumatoid Arthritis Patients: A Study Using Conventional PCR and ELISA Techniques

Mehmet Gökhan Halıcı, Farah Thamer Samawi, Abdullah AbdulKareem Ahmed Al-Obaidi
article en

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation and progressive joint destruction. Increasing evidence suggests that fungal dysbiosis may influence immune responses through the interleukin-17A (IL-17A) pathway. This study aimed to determine the prevalence of peripheral blood Candida albicans DNA in patients with RA, quantify serum IL-17A concentrations, and evaluate the association between fungal DNA positivity and IL-17A levels. A total of 100 participants, including 50 patients with RA and 50 healthy controls, were enrolled. Candida albicans DNA was detected by conventional polymerase chain reaction (PCR) targeting the INT1 gene, while serum IL-17A concentrations were measured using enzyme-linked immunosorbent assay (ELISA). The association between fungal DNA positivity and serum IL-17A concentrations was assessed using point-biserial correlation analysis. Candida albicans DNA was detected significantly more frequently in RA patients than in healthy controls (38% vs. 10%; p < 0.001). Serum IL-17A concentrations were significantly higher in RA patients, with the highest levels observed in C. albicans-positive patients (46.2 ± 8.7 pg/mL), followed by C. albicans-negative RA patients (32.5 ± 6.4 pg/mL) and healthy controls (15.1 ± 5.2 pg/mL) (p < 0.001). Point-biserial correlation analysis demonstrated a significant positive association between C. albicans DNA positivity and serum IL-17A concentrations (rpb = 0.672, p < 0.001). Peripheral blood Candida albicans DNA positivity was associated with elevated serum IL-17A concentrations in patients with RA. These findings support an association between fungal DNA detection and enhanced IL-17A-mediated immune responses; however, the cross-sectional design precludes any inference of causality. Further longitudinal studies incorporating quantitative fungal detection are warranted.

International Journal of Molecular SciencesVol. 27(15)
University of Baghdad (IQ), Nahrain University (IQ), Erciyes University (TR)
Good health and well-being
Openalex Percentile: Top 15%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.